Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Turkish Society of Cardiology consensus paper on the rational use of cardiac troponins in daily practice.

Okyay K, Sadıç BÖ, Şahinarslan A, Durakoğlugil ME, Karabay CY, Eryüksel SE, Gülbahar Ö, Tekin A, Yıldırır A, Görenek B, Yavuzgil O, Fak AS.

Anatol J Cardiol. 2019 Jun;21(6):331-344. doi: 10.14744/AnatolJCardiol.2019.42247. Epub 2019 Apr 19. No abstract available.

2.

Predictive value of CHA2DS2-VASc and CHA2DS2-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction.

Kilic S, Kocabas U, Can LH, Yavuzgil O, Çetin M, Zoghi M.

Cardiol J. 2019;26(2):169-175. doi: 10.5603/CJ.a2018.0017. Epub 2018 Mar 7.

3.

The Severity of Coronary Arterial Stenosis in Patients With Acute ST-Elevated Myocardial Infarction: A Thrombolytic Therapy Study.

Kilic S, Kocabas U, Can LH, Yavuzgil O, Zoghi M.

Cardiol Res. 2018 Feb;9(1):11-16. doi: 10.14740/cr639w. Epub 2018 Feb 11.

4.

Chronic Papillary Muscle Rupture: 14-Year Survival without Surgical Treatment.

Tuluce SY, Tuluce K, Yuksel A, Yavuzgil O, Cinar CS.

Acta Cardiol Sin. 2015 Mar;31(2):172-4.

5.

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

Pokorney SD, Piccini JP, Stevens SR, Patel MR, Pieper KS, Halperin JL, Breithardt G, Singer DE, Hankey GJ, Hacke W, Becker RC, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM; ROCKET AF Steering Committee & Investigators; ROCKET AF Steering Committee Investigators.

J Am Heart Assoc. 2016 Mar 8;5(3):e002197. doi: 10.1161/JAHA.115.002197.

6.

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.

Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M; PARADIGM-HF Investigators and Committees.

Circ Heart Fail. 2016 Jan;9(1). pii: e002560. doi: 10.1161/CIRCHEARTFAILURE.115.002560.

7.

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.

Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC; PARADIGM-HF Investigators and Coordinators.

Circulation. 2015 Jan 6;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748. Epub 2014 Nov 17.

PMID:
25403646
8.

The left atrial phasic functions and the relationship with plasma N-terminal pro-B-type natriuretic peptide levels and symptomatic states in patients with hypertrophic cardiomyopathy.

Tülüce K, Yakar Tülüce S, Yavuzgil O, İsayev E, Bilgin M, Akyıldız Akçay F, Nalbantgil S, Özerkan F.

Anadolu Kardiyol Derg. 2014 Dec;14(8):719-27. doi: 10.5152/akd.2014.5101. Epub 2014 Feb 10.

9.

Angiotensin-neprilysin inhibition versus enalapril in heart failure.

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees.

N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.

10.

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

O'Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators, Steen DL.

JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061. Erratum in: JAMA. 2014 Oct 8;312(14):1473. Dylan P. Steen[corrected to Dylan L. Steen].

PMID:
25173516
11.

Hereditary thrombophilia (factor V R2-mutation) as a contributing factor in premature myocardial infarction associated with pregnancy.

Kayıkçıoğlu M, Yavuzgil O, Eroğlu Z, Onay H, Ergenoğlu M, Can L.

Anadolu Kardiyol Derg. 2014 Nov;14(7):652-4. doi: 10.5152/akd.2014.5506. Epub 2014 Aug 22. No abstract available.

12.

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA; ROCKET AF Steering Committee and Investigators.

Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3. Erratum in: Circulation. 2018 Dec 18;138(25):e783.

13.

Relationships between P wave dispersion, atrial electromechanical delay, left atrial remodeling, and NT-proBNP levels, in patients with hypertrophic cardiomyopathy.

Tuluce K, Ozerkan F, Yakar Tuluce S, Yavuzgil O, Gurgun C, Bilgin M, Kahya Eren N, Kocabas U, Nalbantgil S, Soydas Cinar C.

Cardiol J. 2015;22(1):94-100. doi: 10.5603/CJ.a2014.0025. Epub 2014 Mar 27.

PMID:
24671901
14.

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators.

Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5.

15.

Time course of recovery of left ventricular systolic dysfunction in patients with premature ventricular contraction-induced cardiomyopathy.

Hasdemır C, Kartal Y, Sımsek E, Yavuzgıl O, Aydın M, Can LH.

Pacing Clin Electrophysiol. 2013 May;36(5):612-7. doi: 10.1111/pace.12087. Epub 2013 Feb 4.

PMID:
23379975
16.

Stress cardiomyopathy (Tako-Tsubo) associated with sustained polymorphic ventricular tachycardia.

Hasdemir C, Vuran O, Yuksel A, Yavuzgil O.

Pacing Clin Electrophysiol. 2013 Apr;36(4):e111-4. doi: 10.1111/j.1540-8159.2012.03431.x. Epub 2012 May 31.

PMID:
22650252
17.

Two different pentalogies in an adult patient: a pentalogy of Cantrell associated with a pentalogy of Fallot.

Tuluce K, Gurgun C, Yavuzgil O, Ceylan N, Tuluce SY.

Eur Heart J Cardiovasc Imaging. 2012 Oct;13(10):878-9. doi: 10.1093/ehjci/jes076. Epub 2012 Apr 18. No abstract available.

PMID:
22514008
18.

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KA, Hacke W; ROCKET AF Steering Committee Investigators.

Lancet Neurol. 2012 Apr;11(4):315-22. doi: 10.1016/S1474-4422(12)70042-X. Epub 2012 Mar 7.

PMID:
22402056
19.

Cardiac resynchronization therapy with or without anatomical reverse remodeling does not affect defibrillation threshold.

Kartal Y, Yavuzgil O, Bozoglu M, Alp A, Can LH, Hasdemir C.

Pacing Clin Electrophysiol. 2012 Apr;35(4):416-21. doi: 10.1111/j.1540-8159.2011.03326.x. Epub 2012 Feb 3.

PMID:
22303933
20.

An observational study to evaluate the clinical practice of cardiovascular risk management among hypertensive patients in Turkey.

Kozan O; RiskMan Study Group.

Turk Kardiyol Dern Ars. 2011 Sep;39(6):445-55. doi: 10.5543/tkda.2011.01592.

Supplemental Content

Loading ...
Support Center